Alaunos Therapeutics (TCRT) Shares Outstanding (2009 - 2026)

Alaunos Therapeutics (TCRT) has 18 years of Shares Outstanding (Entity) data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 21.68% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 21.68% YoY) and the FY2025 annual result came in at $1.9 million, up 21.68% from the prior year.
• Shares Outstanding (Entity) steadied at $1.9 million in Q1 2026, from $1.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $2.2 million in Q3 2025 to a low of $1.4 million in Q1 2022.
• A 5-year average of $1.7 million and a median of $1.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slipped 0.19% — and 2025, when it soared 37.76%.
• Tracing TCRT's Shares Outstanding (Entity) over 5 years: stood at $1.6 million in 2022, then decreased by 0.1% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then increased by 21.68% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.